Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Frontline of ASCT in High-risk DLBCL

NCT05831865

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

NCT05842707

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shanghai Tongji Hospital, Tongji University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

NCT05840575

Conditions: Cancer, Chemically-Induced Disorders, Chemo-brain, +37 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04920617

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Compassionate Cancer Care Medical Group Fountain Valley, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

BRCR Medical Center Inc. Hollywood, Florida, United States

BRCR Medical Center Inc. Plantation, Florida, United States

View all 50 locations

View Trial Details

Recruiting

A Registry Study on HIV-related Lymphoma

NCT05231135

Conditions: AIDS Related Lymphoma, HIV Related Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Red Cross Hospital Munich Munich, Select One Option, Germany

University Hospital Cologne Cologne, Germany

Amsterdam University Medical Centers Amsterdam, Netherlands

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Recruiting

A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma

NCT05521802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institute of Hematology and Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

NCT05648019

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more
Locations: Singapore General Hospital Singapore

KK Women's and Children's Hospital Singapore

View Trial Details

Recruiting

Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

NCT05210907

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

NCT05682131

Conditions: Arsenic Trioxide, Childhood ALL, Hematologic Diseases, +10 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

NCT05659628

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital Hangzhou, Zhejiang, China

Ningbo First Hospital Ningbo, Zhejiang, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions